| Identification | |
| Name: | 1-[4-(2-morpholin-4-yl-2-oxoethyl)piperazin-1-yl]pyrimidine-2,4,6(1H,3H,5H)-trione |
| Synonyms: | 4-((4-(Tetrahydro-2,4,6-trioxo-1(2H)-pyrimidinyl)-1-piperazinyl)acetyl)morpholine;2,4,6(1H,3H,5H)-Pyrimidinetrione, 1-(4-(2-(4-morpholinyl)-2-oxoethyl)-1-piperazinyl)-;Morpholine, 4-((4-(tetrahydro-2,4,6-trioxo-1(2H)-pyrimidinyl)-1-piperazinyl)acetyl)-;AC1MI6DR;LS-93444;1-[4-(2-morpholin-4-yl-2-oxoethyl)piperazin-1-yl]-1,3-diazinane-2,4,6-trione;42445-91-0 |
| CAS: | 42445-91-0 |
| Molecular Formula: | C14H21N5O5 |
| Molecular Weight: | 339.347 |
| InChI: | InChI=1/C14H21N5O5/c20-11-9-12(21)19(14(23)15-11)18-3-1-16(2-4-18)10-13(22)17-5-7-24-8-6-17/h1-10H2,(H,15,20,23) |
| Molecular Structure: |  |
| Properties | |
| Density: | 1.407g/cm3 |
| Refractive index: | 1.579 |
| Safety Data | |
 |
|
